Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
about
Beneficial role of rapamycin in experimental autoimmune myositisLoss of β-catenin triggers oxidative stress and impairs hematopoietic regeneration.Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors.Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease.Tolerance after solid organ and hematopoietic cell transplantation.In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice.Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.Effects of FVIII immunity on hepatocyte and hematopoietic stem cell-directed gene therapy of murine hemophilia A.The role of dendritic cells in the generation of CD4(+) CD25(HI) Foxp3(+) T cells induced by amino acid copolymersTwenty years of experience on stem cell transplantation in iran.Clinical perspectives for regulatory T cells in transplantation tolerance.Developing immunologic tolerance for transplantation at the fetal stage.The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.Regulatory immune cells in transplantation.Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis.Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence.IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo.Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy.Adoptive T Regulatory Cell Therapy for Tolerance Induction.Expanding antigen-specific regulatory networks to treat autoimmunity.Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation.Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis.Both rejection and tolerance of allografts can occur in the absence of secondary lymphoid tissues.Regulatory T cell-mediated control of autoantibody-induced inflammation.Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.Mechanisms of tolerance.Engraftment efficacy of human hematopoietic stem cells transplanted into NOD/SCID mice using two methods: intra-bone marrow transplantation of hematopoietic stem cells and intravenous co-transplantation with mesenchymal stem cells.
P2860
Q27306863-211DAB26-F809-43C5-B864-3108DAF5D7DEQ33600256-9B5DD7F7-9DE9-4B03-AE44-52DC73FC277CQ33755190-CC8F7CD5-AAD2-4FC7-9A44-C9226B423446Q35798826-20EF6D3B-0EC8-4F45-A0A2-379EEBF2369DQ35865094-77B83CCE-6BED-4BFE-82D4-B764376EA2CAQ36030385-512CCF59-B4A3-40E8-A39B-2B74FA8C8A37Q36537036-A5336A85-54BC-4CB6-B5DC-D45BE702282FQ36547819-B7B7B553-830F-49F7-8B46-98465CA6DC2BQ36571141-124D536C-AAD4-432A-9841-1CDE50EB1720Q36749505-326F0E59-B888-407E-868E-73647B3EBDB3Q36839332-4E807E48-FFC9-4DC2-8A47-4A21AC55CA9DQ37912653-673908C8-8E50-438B-9AFD-C6535F75567FQ37957143-B82E4157-A0FC-4F8E-8168-E43CD03A0B61Q38008355-AA622228-A941-4357-B17C-91787E8A4196Q38013048-BF3A33ED-44B1-491F-83AB-62E0B86A0527Q38078552-7E083929-6587-49AD-8683-48A170BDA352Q38191280-6784C616-872B-4C37-B6A6-B1B3C5C754B8Q38197678-F93E3D85-A2AE-4938-87E9-2E47466DBC65Q39076791-83A10992-EAE0-463E-ACA8-574176004558Q39414681-C0E51A9F-2607-477A-B83F-B25863388C87Q40132561-AFD9171B-53C4-42A8-AA02-DC8558CEC7E4Q40787726-99A86BE1-7DC3-4707-B22A-3394948803E2Q41453938-B16EC660-29D8-40DB-B934-4B40C961007AQ41841645-CD76F64E-5400-451D-965B-2BD0EFFA7F27Q42087892-98CF4966-8C93-4B04-AA37-57BF8F5B335FQ42144593-4353F49D-F87A-4B78-9985-BCBD5562BE35Q42907197-FA327401-FF01-449B-906C-DE31E01DA34DQ53906830-D71B137F-2FF7-4E1E-9F6F-2AB7BAB8335CQ54577571-CD64F00B-4AEE-4682-9B85-916BEDDA4DDC
P2860
Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
@en
Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
@nl
type
label
Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
@en
Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
@nl
prefLabel
Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
@en
Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
@nl
P2093
P2860
P1476
Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
@en
P2093
Barbarella Lucarelli
Fabio Ciceri
Maria-Grazia Roncarolo
Rosa Bacchetta
Silvia Gregori
P2860
P304
P356
10.1111/J.1600-065X.2011.01010.X
P577
2011-05-01T00:00:00Z